0001685325-21-000001.txt : 20210917 0001685325-21-000001.hdr.sgml : 20210917 20210917142738 ACCESSION NUMBER: 0001685325-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210917 DATE AS OF CHANGE: 20210917 EFFECTIVENESS DATE: 20210917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hunterian Medicine LLC CENTRAL INDEX KEY: 0001685325 IRS NUMBER: 813885060 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-271156 FILM NUMBER: 211259980 BUSINESS ADDRESS: STREET 1: 100 PACIFIC STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 888-486-8633 MAIL ADDRESS: STREET 1: 100 PACIFIC STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D/A 1 primary_doc.xml X0708 D/A LIVE 0001685325 Hunterian Medicine LLC 100 PACIFIC STREET CAMBRIDGE MA MASSACHUSETTS 02139 888-486-8633 DELAWARE Hunterian Medicine, Inc. None Limited Liability Company true Vinod Jaskula-Ranga 100 Pacific Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director James Akiva Silverglad 100 Landsdowne Street #1114 Cambridge MA MASSACHUSETTS 02139 Promoter Biotechnology Decline to Disclose 06b true 0001685325-20-000001 2016-09-11 true true true Debt convertible to preferred securities. false 50000 Indefinite 3880000 Indefinite false 20 0 0 0 true The proceeds of the offering will be used for general working capital purposes including the payment of payroll. The persons listed in Item 3 will be among the issuer's employees who may receive a portion of regularly scheduled salary from such proceeds. false Hunterian Medicine LLC James Silverglad James Silverglad General Counsel 2021-09-17